Abstract
Beta-adrenergic receptors (beta-ARs) belong to a large family of G-protein-coupled receptors (GPCRs) that form the interface between the sympathetic nervous system and the cardiovascular system. The beta-AR signal system is one of the most powerful regulators of cardiac function, mediated by the effects of the sympathetic transmitters epinephrine and norepinephrine. In a number of cardiac diseases, however, the biology of beta-AR signaling pathways is altered dramatically. Here we discuss the role of beta-AR signaling in the normal and abnormal heart and how the use of genetically engineered mouse models has helped in our understanding of the pathophysiology of cardiac disease.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Animals
-
Cardiomegaly / genetics
-
Cardiomyopathies / genetics
-
Cyclic AMP-Dependent Protein Kinases / genetics
-
Cyclic AMP-Dependent Protein Kinases / physiology
-
Disease Models, Animal
-
Heart Diseases / etiology
-
Heart Diseases / genetics*
-
Heart Diseases / physiopathology
-
Heart Failure / genetics
-
Humans
-
Mice
-
Mice, Knockout
-
Models, Cardiovascular
-
Phosphatidylinositol 3-Kinases / genetics
-
Receptors, Adrenergic, beta / genetics
-
Receptors, Adrenergic, beta / physiology*
-
Signal Transduction
-
beta-Adrenergic Receptor Kinases
Substances
-
Receptors, Adrenergic, beta
-
Phosphatidylinositol 3-Kinases
-
Cyclic AMP-Dependent Protein Kinases
-
beta-Adrenergic Receptor Kinases